{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:29Z","timestamp":1788825629922,"version":"build-2803163510"},"reference-count":59,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Irish Research Council Government of Ireland Postgraduate Research Scholarship"},{"name":"Irish Endocrine Society Basic Science Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Adrenocortical carcinoma (ACC) is a rare aggressive cancer with low overall survival. Adjuvant mitotane improves survival but is limited by poor response rates and resistance. Mitotane\u2019s efficacy is attributed to the accumulation of toxic free cholesterol, predominantly through cholesterol storage inhibition. However, targeting this pathway has proven unsuccessful. We hypothesize that mitotane-induced free-cholesterol accumulation is also mediated through enhanced breakdown of lipid droplets.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methodology<\/jats:title>\n                  <jats:p>ATCC-H295R (mitotane-sensitive) and MUC-1 (mitotane-resistant) ACC cells were evaluated for lipid content using specific BODIPY dyes. Protein expression was evaluated by immunoblotting and flow cytometry. Cell viability was measured by quantifying propidium iodide-positive cells following mitotane treatment and pharmacological inhibitors of lipolysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>H295R and MUC-1 cells demonstrated similar neutral lipid droplet numbers at baseline. However, evaluation of lipid machinery demonstrated distinct profiles in each model. Analysis of intracellular lipid droplet content showed H295R cells preferentially store cholesteryl esters, whereas MUC-1 cells store triacylglycerol. Decreased lipid droplets were associated with increased lipolysis in H295R and in MUC-1 at toxic mitotane concentrations. Pharmacological inhibition of lipolysis attenuated mitotane-induced toxicity in both models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We highlight that lipid droplet breakdown and activation of lipolysis represent a putative additional mechanism for mitotane-induced cytotoxicity in ACC. Further understanding of cholesterol and lipids in ACC offers potential novel therapeutic exploitation, especially in mitotane-resistant disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/endocr\/bqac102","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T20:37:33Z","timestamp":1657226253000},"source":"Crossref","is-referenced-by-count":12,"title":["Mitotane Targets Lipid Droplets to Induce Lipolysis in Adrenocortical Carcinoma"],"prefix":"10.1210","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-294X","authenticated-orcid":false,"given":"Kate M","family":"Warde","sequence":"first","affiliation":[{"name":"Discipline of Pharmacology and Therapeutics, National University of Ireland, Galway , H91 TK33 , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Jan","family":"Lim","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacology and Therapeutics, National University of Ireland, Galway , H91 TK33 , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ribes Martinez","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacology and Therapeutics, National University of Ireland, Galway , H91 TK33 , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-3984","authenticated-orcid":false,"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital, Ludwig Maximilian University of Munich , Munich , 81377 , Germany"},{"name":"Department of Endocrinology, Diabetes, and Clinical Nutrition, University Hospital Zurich, Zurich 8091 , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"O\u2019Shea","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Galway University Hospitals, Saolta Hospitals Group , Newcastle Road, Galway , H91 RW28 , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Hantel","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital, Ludwig Maximilian University of Munich , Munich, 81377 , Germany"},{"name":"Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden , 01307 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9325-6520","authenticated-orcid":false,"given":"Michael Conall","family":"Dennedy","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacology and Therapeutics, National University of Ireland, Galway , H91 TK33 , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"issue":"10","key":"2022080117101251400_CIT0001","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Libe","year":"2015","journal-title":"Ann Oncol."},{"issue":"11","key":"2022080117101251400_CIT0002","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer."},{"issue":"1","key":"2022080117101251400_CIT0003","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1245\/s10434-015-4803-x","article-title":"Adrenocortical carcinoma: impact of surgical margin status on long-term outcomes","volume":"23","author":"Margonis","year":"2016","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"2022080117101251400_CIT0004","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1210\/jc.2016-2894","article-title":"Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma","volume":"102","author":"Berruti","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"23","key":"2022080117101251400_CIT0005","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med."},{"issue":"3","key":"2022080117101251400_CIT0006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1530\/EJE-13-0242","article-title":"Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection","volume":"169","author":"Terzolo","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"1-2","key":"2022080117101251400_CIT0007","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2013.07.023","article-title":"Lack of long-lasting effects of mitotane adjuvant therapy in a mouse xenograft model of adrenocortical carcinoma","volume":"381","author":"Doghman","year":"2013","journal-title":"Mol Cell Endocrinol."},{"issue":"4","key":"2022080117101251400_CIT0008","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1677\/ERC-08-0103","article-title":"Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly","volume":"15","author":"Daffara","year":"2008","journal-title":"Endocr Relat Cancer."},{"issue":"11","key":"2022080117101251400_CIT0009","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1210\/en.2015-1367","article-title":"Mitotane inhibits sterol-o-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells","volume":"156","author":"Sbiera","year":"2015","journal-title":"Endocrinology."},{"issue":"8","key":"2022080117101251400_CIT0010","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1210\/JC.2015-2080","article-title":"Lipoprotein-free mitotane exerts high cytotoxic activity in adrenocortical carcinoma","volume":"100","author":"Hescot","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"66","key":"2022080117101251400_CIT0011","doi-asserted-by":"crossref","first-page":"109924","DOI":"10.18632\/oncotarget.18968","article-title":"Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approaches","volume":"8","author":"Hescot","year":"2017","journal-title":"Oncotarget."},{"issue":"7","key":"2022080117101251400_CIT0012","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI28400","article-title":"Liver X receptors regulate adrenal cholesterol balance","volume":"116","author":"Cummins","year":"2006","journal-title":"J Clin Invest."},{"key":"2022080117101251400_CIT0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2016.07.034","article-title":"SNAREs and cholesterol movement for steroidogenesis","volume":"441","author":"Kraemer","year":"2017","journal-title":"Mol Cell Endocrinol."},{"key":"2022080117101251400_CIT0014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2006.12.001","article-title":"Adrenal cholesterol utilization","volume":"265-266","author":"Kraemer","year":"2007","journal-title":"Mol Cell Endocrinol."},{"issue":"3","key":"2022080117101251400_CIT0015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/me.2003-0179","article-title":"Hormone-sensitive lipase is required for high-density lipoprotein cholesteryl ester-supported adrenal steroidogenesis","volume":"18","author":"Kraemer","year":"2004","journal-title":"Mol Endocrinol."},{"issue":"4","key":"2022080117101251400_CIT0016","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1194\/jlr.M700475-JLR200","article-title":"Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting","volume":"49","author":"Hoekstra","year":"2008","journal-title":"J Lipid Res."},{"issue":"6257","key":"2022080117101251400_CIT0017","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature."},{"issue":"2","key":"2022080117101251400_CIT0018","doi-asserted-by":"crossref","first-page":"E408","DOI":"10.1152\/ajpendo.00428.2006","article-title":"The LDL receptor is not necessary for acute adrenal steroidogenesis in mouse adrenocortical cells","volume":"292","author":"Kraemer","year":"2007","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"48","key":"2022080117101251400_CIT0019","doi-asserted-by":"crossref","first-page":"45456","DOI":"10.1074\/jbc.M104436200","article-title":"Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway","volume":"276","author":"Greenberg","year":"2001","journal-title":"J Biol Chem."},{"issue":"3","key":"2022080117101251400_CIT0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/endo.143.3.8693","article-title":"Adrenal neutral cholesteryl ester hydrolase: identification, subcellular distribution, and sex differences","volume":"143","author":"Kraemer","year":"2002","journal-title":"Endocrinology."},{"key":"2022080117101251400_CIT0021","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-nutr-071813-105410","article-title":"The perilipins: major cytosolic lipid droplet-associated proteins and their roles in cellular lipid storage, mobilization, and systemic homeostasis","volume":"36","author":"Kimmel","year":"2016","journal-title":"Annu Rev Nutr."},{"issue":"Pt 17","key":"2022080117101251400_CIT0022","first-page":"4067","article-title":"Perilipin family members preferentially sequester to either triacylglycerol-specific or cholesteryl-ester-specific intracellular lipid storage droplets","volume":"125","author":"Hsieh","year":"2012","journal-title":"J Cell Sci."},{"issue":"1","key":"2022080117101251400_CIT0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plipres.2010.10.004","article-title":"Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores","volume":"50","author":"Lass","year":"2011","journal-title":"Prog Lipid Res."},{"issue":"11","key":"2022080117101251400_CIT0024","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1194\/jlr.M900176-JLR200","article-title":"Functional interaction of hormone-sensitive lipase and perilipin in lipolysis","volume":"50","author":"Shen","year":"2009","journal-title":"J Lipid Res."},{"issue":"11","key":"2022080117101251400_CIT0025","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1172\/JCI118716","article-title":"Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production","volume":"97","author":"Plump","year":"1996","journal-title":"J Clin Invest."},{"issue":"5","key":"2022080117101251400_CIT0026","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-2275(20)41288-X","article-title":"ACTH-induced hydrolysis of cholesteryl esters in rat adrenal cells","volume":"19","author":"Vahouny","year":"1978","journal-title":"J Lipid Res."},{"issue":"21","key":"2022080117101251400_CIT0027","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1158\/1078-0432.CCR-15-2973","article-title":"Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis","volume":"22","author":"Geng","year":"2016","journal-title":"Clin Cancer Res."},{"issue":"1","key":"2022080117101251400_CIT0028","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41467-017-02732-5","article-title":"Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance","volume":"9","author":"Cotte","year":"2018","journal-title":"Nat Commun."},{"issue":"11","key":"2022080117101251400_CIT0029","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/s41590-020-0783-5","article-title":"Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis","volume":"21","author":"Li","year":"2020","journal-title":"Nat Immunol."},{"key":"2022080117101251400_CIT0030","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31132","article-title":"Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia","volume":"6","author":"Zhang","year":"2017","journal-title":"Elife."},{"issue":"3","key":"2022080117101251400_CIT0031","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-15-0946","article-title":"Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma","volume":"174","author":"Kroiss","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"2022080117101251400_CIT0032","first-page":"150135","article-title":"Dyslipidemia causes overestimation of plasma mitotane measurements","volume":"2016","author":"Paci","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"issue":"6","key":"2022080117101251400_CIT0033","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/ERC-20-0031","article-title":"Liver X receptor inhibition potentiates mitotane-induced adrenotoxicity in ACC","volume":"27","author":"Warde","year":"2020","journal-title":"Endocr Relat Cancer."},{"key":"2022080117101251400_CIT0034","doi-asserted-by":"crossref","first-page":"624962","DOI":"10.1155\/2013\/624962","article-title":"Mitotane-induced hyperlipidemia: a retrospective cohort study","volume":"2013","author":"Shawa","year":"2013","journal-title":"Int J Endocrinol."},{"issue":"9","key":"2022080117101251400_CIT0035","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-19-1063","article-title":"Statins reduce intratumor cholesterol affecting adrenocortical cancer growth","volume":"19","author":"Trotta","year":"2020","journal-title":"Mol Cancer Ther."},{"issue":"48","key":"2022080117101251400_CIT0036","doi-asserted-by":"crossref","first-page":"79292","DOI":"10.18632\/oncotarget.12685","article-title":"Targeting heterogeneity of adrenocortical carcinoma: evaluation and extension of preclinical tumor models to improve clinical translation","volume":"7","author":"Hantel","year":"2016","journal-title":"Oncotarget."},{"issue":"17","key":"2022080117101251400_CIT0037","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1912","article-title":"BODIPY 493\/503 staining of neutral lipid droplets for microscopy and quantification by flow cytometry","volume":"6","author":"Qiu","year":"2016","journal-title":"Bio Protoc."},{"issue":"6","key":"2022080117101251400_CIT0038","doi-asserted-by":"crossref","first-page":"e0128903","DOI":"10.1371\/journal.pone.0128903","article-title":"LDL receptor-related protein-1 (LRP1) regulates cholesterol accumulation in macrophages","volume":"10","author":"Lillis","year":"2015","journal-title":"PLoS One."},{"issue":"1","key":"2022080117101251400_CIT0039","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1074\/jbc.274.1.41","article-title":"Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake","volume":"274","author":"Connelly","year":"1999","journal-title":"J Biol Chem."},{"issue":"16","key":"2022080117101251400_CIT0040","doi-asserted-by":"crossref","first-page":"11811","DOI":"10.1016\/S0021-9258(19)50272-1","article-title":"CD36 is a receptor for oxidized low density lipoprotein","volume":"268","author":"Endemann","year":"1993","journal-title":"J Biol Chem."},{"key":"2022080117101251400_CIT0041","article-title":"Supplementary File_Warde et al., 2022","author":"Warde","year":"2022","journal-title":"Figshare"},{"issue":"2","key":"2022080117101251400_CIT0042","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41416-019-0658-4","article-title":"MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming","volume":"122","author":"Zhang","year":"2020","journal-title":"Br J Cancer."},{"issue":"29","key":"2022080117101251400_CIT0043","doi-asserted-by":"crossref","first-page":"28282","DOI":"10.18632\/oncotarget.5061","article-title":"Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells","volume":"6","author":"Zagani","year":"2015","journal-title":"Oncotarget."},{"key":"2022080117101251400_CIT0044","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-21-2040","article-title":"Single-cell profiling reveals metabolic reprogramming as a resistance mechanism in BRAF-mutated multiple myeloma","author":"Waldschmidt","year":"2021","journal-title":"Clin Cancer Res."},{"issue":"1","key":"2022080117101251400_CIT0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41388-020-01518-2","article-title":"Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma","volume":"40","author":"Nimmakayala","year":"2021","journal-title":"Oncogene."},{"issue":"5","key":"2022080117101251400_CIT0046","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1210\/en.2015-2052","article-title":"ATR-101, a selective and potent inhibitor of Acyl-CoA acyltransferase 1, induces apoptosis in H295R adrenocortical cells and in the adrenal cortex of dogs","volume":"157","author":"LaPensee","year":"2016","journal-title":"Endocrinology."},{"issue":"5","key":"2022080117101251400_CIT0047","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10637-020-00899-1","article-title":"A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma","volume":"38","author":"Smith","year":"2020","journal-title":"Invest New Drugs."},{"issue":"4","key":"2022080117101251400_CIT0048","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1021\/acs.jproteome.7b00782","article-title":"Deletion of adipose triglyceride lipase links triacylglycerol accumulation to a more-aggressive phenotype in A549 lung carcinoma cells","volume":"17","author":"Tomin","year":"2018","journal-title":"J Proteome Res."},{"issue":"22","key":"2022080117101251400_CIT0049","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1158\/0008-5472.CAN-20-1255","article-title":"KRAS controls pancreatic cancer cell lipid metabolism and invasive potential through the lipase HSL","volume":"80","author":"Rozeveld","year":"2020","journal-title":"Cancer Res."},{"issue":"3","key":"2022080117101251400_CIT0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness","volume":"19","author":"Yue","year":"2014","journal-title":"Cell Metab."},{"issue":"11","key":"2022080117101251400_CIT0051","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med."},{"issue":"6","key":"2022080117101251400_CIT0052","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assie","year":"2014","journal-title":"Nat Genet."},{"issue":"2","key":"2022080117101251400_CIT0053","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccell.2016.07.013","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"30","author":"Zheng","year":"2016","journal-title":"Cancer Cell."},{"issue":"11","key":"2022080117101251400_CIT0054","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1158\/1078-0432.CCR-18-2693","article-title":"Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma","volume":"25","author":"Mohan","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"3","key":"2022080117101251400_CIT0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cmet.2010.02.003","article-title":"The G(0)\/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metab."},{"key":"2022080117101251400_CIT0056","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.coemr.2019.08.009","article-title":"Contemporary preclinical human models of adrenocortical carcinoma","volume":"8","author":"Pinto","year":"2019","journal-title":"Curr Opin Endocr Metab Res."},{"issue":"4","key":"2022080117101251400_CIT0057","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/ERC-17-0447","article-title":"Development of new preclinical models to advance adrenocortical carcinoma research","volume":"25","author":"Kiseljak-Vassiliades","year":"2018","journal-title":"Endocr Relat Cancer."},{"issue":"6","key":"2022080117101251400_CIT0058","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/EJE-20-1423","article-title":"A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden","volume":"184","author":"Landwehr","year":"2021","journal-title":"Eur J Endocrinol."},{"key":"2022080117101251400_CIT0059","doi-asserted-by":"crossref","first-page":"669426","DOI":"10.3389\/fendo.2021.669426","article-title":"Cytotoxic effect of progesterone, tamoxifen and their combination in experimental cell models of human adrenocortical cancer","volume":"12","author":"Rossini","year":"2021","journal-title":"Front Endocrinol (Lausanne)."}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqac102\/44581904\/bqac102.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/163\/9\/bqac102\/45210249\/bqac102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/163\/9\/bqac102\/45210249\/bqac102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T17:28:52Z","timestamp":1659374932000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqac102\/6633639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqac102","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,7,7]]},"article-number":"bqac102"}}